These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Research progress of dyskeratosis congenita]. Wang F; Du YQ; Gong W; Sun CK; Zeng X Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):130-134. PubMed ID: 30695916 [TBL] [Abstract][Full Text] [Related]
27. Retinal hemorrhages in a patient with dyskeratosis congenita. Nazir S; Sayani N; Phillips PH J AAPOS; 2008 Aug; 12(4):415-7. PubMed ID: 18455938 [TBL] [Abstract][Full Text] [Related]
28. Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. Erduran E; Hacisalihoglu S; Ozoran Y J Pediatr Hematol Oncol; 2003 Apr; 25(4):333-5. PubMed ID: 12679652 [TBL] [Abstract][Full Text] [Related]
30. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review. Li F; Li W; Qiao X; Xie X Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317 [TBL] [Abstract][Full Text] [Related]
32. [Genetic analysis of a patient with dyskeratosis congenita]. Yoshimoto T; Yanabe Y; Mizukami T; Ishibashi F; Adachi N; Takaki K; Nunoi H Rinsho Ketsueki; 2000 Jun; 41(6):524-9. PubMed ID: 10921354 [TBL] [Abstract][Full Text] [Related]
33. Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge. Manfuso A; Risitano AM; Copelli C BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975847 [TBL] [Abstract][Full Text] [Related]
34. Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation. Ehlert K; Rossig C; Groll AH; Beyna T; Froehlich B; Juergens H J Pediatr Hematol Oncol; 2015 Jan; 37(1):e41-4. PubMed ID: 25000468 [TBL] [Abstract][Full Text] [Related]
35. Hepatic Angiosarcoma with Dyskeratosis Congenita. Horiguchi N; Kakizaki S; Iizuka K; Hagiwara S; Ohyama T; Yamazaki Y; Shibusawa N; Sato K; Kusano M; Nakazato Y; Yamada M Intern Med; 2015; 54(22):2867-72. PubMed ID: 26568000 [TBL] [Abstract][Full Text] [Related]
36. [Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita]. Reiger Z; Varga G; Tóth B; Maródi L; Erdos M Orv Hetil; 2010 Feb; 151(8):285-92. PubMed ID: 20153999 [TBL] [Abstract][Full Text] [Related]
37. Dyskeratosis congenita: oral hyperkeratosis in association with lichenoid reaction. Handley TP; Ogden GR J Oral Pathol Med; 2006 Sep; 35(8):508-12. PubMed ID: 16918603 [TBL] [Abstract][Full Text] [Related]
38. Diffuse Mesangial Sclerosis in a Child With Dyskeratosis Congenita Leading to End-stage Renal Disease. Kamel A; Sayari T; Jellouli M; Hammi Y; Louzir RG; Gargah T Iran J Kidney Dis; 2016 Nov; 10(6):416-418. PubMed ID: 27904002 [TBL] [Abstract][Full Text] [Related]
39. Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita. Bongiorno M; Rivard S; Hammer D; Kentosh J Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Oct; 124(4):e239-e242. PubMed ID: 28923296 [TBL] [Abstract][Full Text] [Related]
40. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Ballew BJ; Savage SA Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]